多药丸对坚持和心血管结果的影响:综合系统性综述与元分析
Hamza Salim1, Basel Musmar1, Motaz Saifi1
1Department of Medicine, An-Najah National University, Nablus, Palestine.
多药可显著降低心血管疾病风险因素,如血压和主要心血管不良事件 (MACE). 改善对多种药物的药物坚持可能是这些好处的关键.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心血管疾病 (CVD) 是全球领先的健康问题.
- 多种药丸提供了一种改善预防心血管疾病的药物坚持的策略.
- 需要证据来比较多药丸与常规治疗心血管疾病的结果.
研究的目的:
- 评估多药对心血管风险因素的影响.
- 评估多药对重大心血管不良事件 (MACE) 的影响.
- 为了确定多药丸对药物坚持的影响.
主要方法:
- 随机对照试验和观察性研究的元分析.
- 多种药丸与常规护理的比较.
- 结果:血压,脂质概况,MACE和药物坚持.
主要成果:
- 多种药物显著降低了静缩和静缩血压 (SBP,DBP).
- 在使用多种药丸时,观察到MACE风险显著降低.
- 服用多种药物的药物坚持率提高了17%,这可能导致血压降低.
结论:
- 多种药丸在减少关键心血管风险因素和MACE方面表现出有效性.
- 提高药物坚持是多药丸使用的一个显著好处.
- 个性化多药剂方法可能进一步优化心血管疾病的结果.
更多相关视频
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
The Placebo Effect
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Therapy
Antianxiety Medications
Cardiovascular Drugs: Classification based on Therapeutic Indications
